Retinitis Pigmentosa (RP) Market : Sucampo Pharmaceuticals, Orphagen Pharmaceuticals, Inc., Inc
The global retinitis pigmentosa market has been treading a healthy growth path due to limited availability of therapeutics to cure this rare disease which has opened up a window of opportunity for new therapies and treatments.
View full press release